Boston Scientific strikes $325M Millipede mitral valve repair buyout

The takeover gives Boston Scientific a foothold in a market predicted to grow to $1 billion by 2021.

By Nick Paul Taylor • Jan. 3, 2019

Regulatory makeovers and international game changers: MedTech Dive's top stories of 2018

Hard looks at cybersecurity and digital health's hot streak also left their mark on the year.

By Maria Rachal • Dec. 22, 2018

3M completes acquisition of MModal's tech business for $1B

The manufacturer plans to use MModal's cloud-based, conversational AI technology in areas like population health, where 3M is already active. 

By Meg Bryant • Updated Feb. 4, 2019

Medtronic launches spinal surgery system with Mazor technology

U.S. patients are now being treated with Medtronic's fully-integrated spinal surgery system, born from the 2018 buyout of Israel's Mazor Robotics.

By Maria Rachal • Updated Jan. 28, 2019

Smith & Nephew completes meniscus repair acquisition

The company said Tuesday its $50 million purchase of Ceterix Orthopaedics has closed, with additional payouts up to $55 million possible over the next five years based on the associated meniscal repair system's financial performance.

By Maria Rachal • Updated Jan. 23, 2019

Livongo names Cerner's Burke as new CEO

Current CEO Glen Tullman will take the title of executive chairman. Tullman told MedTech Dive in an interview before the move that revenue is set to more than double in 2018 to about $61 million.

By David Lim • Dec. 19, 2018

Allscripts to sell stake in Netsmart for $525M

The EHR vendor said the sale will allow it to pay back long-term debt and invest in other areas.

By Samantha Liss • Dec. 11, 2018

ResMed buys maker of COPD, asthma monitoring platform

The acquisition of Propeller follows a growing trend by device makers to acquire or partner with digital technology companies. 

By Susan Kelly • Dec. 5, 2018

The MedTech Dive Awards of 2018

The awards recognize the industry's top disruptors and newsmakers. These officials and companies are shaking up the medical technology sector and shaping the future.

By MedTech Dive Team • Dec. 3, 2018

CVS-Aetna megamerger finalized

The total value of the acquisition, including assumption of Aetna's debt, clocks in at $78 billion. The union creates the second biggest private company by revenue after Walmart.

By Rebecca Pifer • Nov. 28, 2018

Quest closes buy of Midwest lab services business

Completion of the deal for Columbia, Missouri-based Boyce and Bynum Pathology Laboratories comes as the lab services giant prepares to release financial results later this week.

By Susan Kelly • Updated Feb. 12, 2019

Boston Scientific snags BTG for $4.2B

The Federal Trade Commission cleared the merger and the deal is now slated to take effect Aug. 19, Boston Scientific said in an SEC filing Wednesday, a month after it addressed antitrust concerns by divesting its beads business.

By Nick Paul Taylor • Updated Aug. 7, 2019

Colfax strikes $3.15B buyout of orthopaedics player DJO

The acquisition will move the industrial technology conglomerate into a new market: medical devices.

By Nick Paul Taylor • Nov. 20, 2018

ResMed wraps up $750M MatrixCare buyout in SaaS push

The sleep apnea company has spent almost $1.7 billion on software businesses in recent years.

By Nick Paul Taylor • Nov. 15, 2018

Athenahealth scooped for $5.7B by Elliot, Veritas after turbulent year

Activist investor Elliott has been pushing for a buyout since it sent athenahealth an unsolicited offer in May.

By Tony Abraham • Nov. 12, 2018

Stryker closes $1.4B K2M acquisition

The medical device giant says the deal will augment its own spine and neurotechnology offerings.

By David Lim • Nov. 9, 2018

Premier to acquire software company Stanson Health for $51.5M

Software-as-a-service provider Stanson's product pipeline includes a tool to give prior authorizations in near real time.

By Meg Bryant • Nov. 8, 2018

Execs bullish on IT, home health, M&A for 2019

More than 70% of executives predict better performance in the next 12 months, according to a Capital One survey. About 42% forecast increased deal activity.

By Meg Bryant • Nov. 6, 2018

Fresh off of strong quarter, ResMed buys MatrixCare

The sleep apnea company is betting the acquisition will augment its existing software-as-a-service offerings such as Brightree and HEALTHCAREfirst.

By David Lim • Nov. 6, 2018

Healthcare startups raise $26B in 2018, eclipsing prior years

Venture capital funding through October surpassed the total raised in 2012 and 2013 combined, according to a Pitchbook analysis for Forbes.

By Meg Bryant • Nov. 5, 2018

Boston Scientific posts strong Q3 with 8.7% sales growth

Coming off a legal win in a patent battle with Edwards, the CEO held his cards close to the vest on next steps on the earnings call.  

By David Lim • Updated Oct. 25, 2018

Stryker closes Invuity acquisition

Invuity's CEO called out "a lack of strategic organizational alignment in our sales and marketing efforts" during its Q2 earnings call, something that Stryker may be well positioned to help fix. 

By David Lim • Oct. 23, 2018

Cardinal credit downgraded after debt-fueled medtech expansion

Fitch said $9 billion in debt is subject to risks, such as failing to realize the expected synergies from integrating assets bought from Medtronic.

By Nick Paul Taylor • Oct. 19, 2018

Abbott medical device, diagnostic units drive Q3 growth

CEO Miles White said Abbott plans to submit its data to FDA in the coming weeks to back an expanded indication for MitraClip.

By David Lim • Oct. 17, 2018

Boston Scientific closes Augmenix acquisition for $600M

The device giant expects sales of the SpaceOar Hydrogel System to be $50 million in 2018 and $90 million in 2019.

By Rebecca Pifer • Oct. 17, 2018